APOE and atherosclerosis: Taking all these results into consideration, we used orally active, selective Mas receptor agonist AVE0991 to stimulate the Ang‐(1‐7) protective axis in ApoE‐/‐ mice, and studied its effects on atherosclerosis and vascular inflammation.